The Scientific Advisory Board

The Scientific Advisory Board is responsible for providing the Executive Board and Supervisory Board with external specialized knowledge regarding future important research topics and ongoing scientific and strategic issues; it meets every six months. At present the Scientific Advisory Board consists of thirteen international experts in translational research and systems medicine.

Chair of the Scientific Advisory Board

Prof. Stefanie Dimmeler
Institute of Cardiovascular Regeneration - Centre for Molecular Medicine, Frankfurt/Main

Vice Chair

Prof. Jörg Hacker
German National Academy of Sciences Leopoldina, (Halle, Germany)

Members of the Scientific Advisory Board



Prof. Lina Badimon

Institute for Cardiovascular Science, Barcelona, Spain

Prof. Robert C. Bast, Jr., M.D.

The University of Texas MD Anderson Cancer Center, USA

Prof. Elizabeth Blackburn

Salk Institute for Biological Studies, La Jolla, USA

Prof. Alastair Buchan

Medical School und Medical Sciences Division, University of Oxford, United Kingdom

Jan Geissler

Patvocates GmbH, Germany

Prof. Teri Manolio

National Human Genome Research Institute, National Institutes of Health, Bethesda, USA

Prof. Miriam Merad

Mount Sinai School of Medicine, New York, USA

Prof. Sibrand Poppema

University of Groningen, Groningen, Netherlands

Prof. Alan R. Shuldiner

University of Maryland School of Medicine, Baltimore, USA

Prof. Georg Stingl

Medical University of Vienna, Austria

Prof. Thomas C. Südhof

Stanford University School of Medicine, USA

Prof. Sarah Teichmann

Wellcome Trust Sanger Institute, Great Britain, United Kingdom